{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:38:51Z","timestamp":1787668731580,"version":"build-2736575974"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejogrb.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T20:52:52Z","timestamp":1433451172000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Oxidative stress and cardiovascular complications in polycystic ovarian syndrome"],"prefix":"10.1016","volume":"191","author":[{"given":"Barkath Nisha","family":"Hyderali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-9981","authenticated-orcid":false,"given":"Kanchana","family":"Mala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2015.05.005_bib0670","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the south eastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0675","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)53699-1","article-title":"Clinical signs of androgen excess as risk factors for coronary artery disease","volume":"54","author":"Wild","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0680","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00017285-200203000-00006","article-title":"Diet and polycystic ovary syndrome","volume":"37","author":"McKittrick","year":"2002","journal-title":"Nutr Today"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0685","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0690","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0695","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-7827-10-49","article-title":"The effects of oxidative stress on female reproduction: a review","volume":"10","author":"Agarwal","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0700","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0705","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humupd\/4.1.3","article-title":"Role of nitric oxide in the biology, physiology and pathophysiology of reproduction","volume":"4","author":"Rosselli","year":"1998","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0710","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0715","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2013.04.001","article-title":"Redox signaling in cardiovascular health and disease","volume":"61C","author":"Madamanchi","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0720","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.biocel.2010.06.001","article-title":"The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes","volume":"42","author":"Al-Gubory","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0725","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0730","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7827-3-28","article-title":"Role of oxidative stress in female reproduction","volume":"3","author":"Agarwal","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0735","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000113046","article-title":"Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters","volume":"65","author":"Verit","year":"2008","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0740","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jcp.2003.015271","article-title":"Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)","volume":"58","author":"Bickerton","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0745","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000177500","article-title":"The endothelium in coronary artery disease","volume":"88","author":"Ruschitzka","year":"1997","journal-title":"Cardiology"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.10.059","article-title":"Endothelial dysfunction in PCOS: role of obesity and adipose hormones","volume":"119","author":"Carmina","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0755","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","article-title":"Inflammatory and endothelial markers in women with polycystic ovary syndrome","volume":"36","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0760","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0765","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2007-992154","article-title":"Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances","volume":"116","author":"Karadeniz","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0770","first-page":"27","article-title":"Oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome","volume":"1","author":"Karabulut","year":"2012","journal-title":"Med Sci"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0775","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(91)90280-B","article-title":"Cellular injury by oxidants","author":"Cochrane","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0780","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1210\/jc.2011-0651","article-title":"Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance","volume":"96","author":"Victor","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0785","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/00365510500375263","article-title":"DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome","volume":"65","author":"Dincer","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0790","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2015.05.005_bib0795","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/jc.2004-0410","article-title":"Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients","volume":"90","author":"Ciampelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ejogrb.2015.05.005_bib0800","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0805","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and \u03b2-cell function in human subjects: evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0810","first-page":"1052","article-title":"Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance","volume":"78","author":"Holte","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0815","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/humrep\/12.9.1897","article-title":"Heterogeneity in \u03b2-cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome","volume":"12","author":"Ciampelli","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0820","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0026-0495(99)90028-8","article-title":"Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome","volume":"48","author":"Ciampelli","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0825","article-title":"Relationship of advanced glycation end products with cardiovascular disease in menopausal women","author":"Pertynska-Marczewska","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0830","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0835","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardiores.2006.05.001","article-title":"Redox signaling in hypertension","volume":"71","author":"Paravicini","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0840","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14310\/horm.2002.1320","article-title":"Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander?","volume":"10","author":"Christakou","year":"2011","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0845","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0850","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Witko-Sarsat","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0855","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.fertnstert.2008.08.016","article-title":"Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome","volume":"92","author":"Kaya","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0860","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/157340410791321381","article-title":"Female infertility and antioxidants","volume":"6","author":"Sekhon","year":"2010","journal-title":"Curr Womens Health Rev"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0865","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1472-6483(10)62151-7","article-title":"Role of free radicals in female reproductive diseases and assisted reproduction","volume":"9","author":"Agarwal","year":"2004","journal-title":"Reprod Biomed"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0870","first-page":"421","article-title":"The effects of oxidative stress to PCOS","volume":"39","author":"Zhang","year":"2008","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0875","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2006.03061.x","article-title":"The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients","volume":"144","author":"Palacio","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0880","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00016340902859315","article-title":"Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome","volume":"88","author":"Kuscu","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0885","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157340410791321336","article-title":"Role of oxidative stress in polycystic ovary syndrome","volume":"6","author":"Lee","year":"2010","journal-title":"Curr Womens Health Rev"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0890","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0015-0282(03)00571-5","article-title":"Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease","volume":"80","author":"Fenkci","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0895","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7827-7-54","article-title":"Women with endometriosis improved their peripherals antioxidants markers after the application of a high antioxidant diet","volume":"28","author":"Mier-Cabrera","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0900","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0015-0282(02)03133-3","article-title":"N-acetyl cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome","volume":"77","author":"Fulghesu","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0905","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI118394","article-title":"Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus","volume":"97","author":"Ting","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0910","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/01.CIR.96.5.1513","article-title":"Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients","volume":"96","author":"Solzbach","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0915","first-page":"68","article-title":"Serum antioxidant vitamins changes in women with polycystic ovary syndrome","volume":"22","author":"Al-Kataan","year":"2010","journal-title":"J Bahrain Med Soc"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0920","first-page":"1","article-title":"Effects of Omega-3 fatty acid supplement on serum lipid profile and markers of oxidative stress in women with polycystic ovary syndrome","volume":"15","author":"Rafraf","year":"2012","journal-title":"Iran J Obstet Gynecol Infertil"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0925","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/09513590.2012.696753","article-title":"Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome","volume":"28","author":"Pal","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0930","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/117739361000100002","article-title":"Metformin and N-acetyl cysteine in polycystic ovarian syndrome\u2014a comparative study","volume":"1","author":"Gayatri","year":"2010","journal-title":"Indian J Clin Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0935","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1089\/ars.2007.1964","article-title":"Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications","volume":"10","author":"Agarwal","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0940","unstructured":"Nutrition Guide, Human Performance Research Center. http:\/\/hprc-online.org\/nutrition\/warfighter-nutrition-guide-chapter-4-1\/FoodSourcesAntioxidants.pdf."},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0945","doi-asserted-by":"crossref","first-page":"40","DOI":"10.22401\/JNUS.14.1.05","article-title":"Comparative study of antioxidant levels (vitamin E & selenium) in serum of polycystic ovary syndrome patients and control","volume":"14","author":"Hamad","year":"2011","journal-title":"J Al-Nahrain Univ"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0950","series-title":"Drugs and supplements. Vitamin E","author":"Mayo Clinic Medical Information","year":"2005"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0955","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10238-007-0144-y","article-title":"Effects of nutritional supplementation with antioxidant vitamins and minerals and fish oil on antioxidant status and psychosocial stress in smokers: an open trial","volume":"7","author":"Nitta","year":"2007","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0960","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0965","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1990.tb03897.x","article-title":"Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome","volume":"33","author":"Conway","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0970","first-page":"64","volume":"vol. 40","year":"2013"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0975","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0980","first-page":"391","article-title":"Evaluation of insulin resistance and oxidative stress in obese patients with polycystic ovary syndrome","volume":"1","author":"Kandasamy","year":"2010","journal-title":"Int J Appl Biol Pharm Technol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0985","first-page":"E197","article-title":"Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0990","first-page":"528","article-title":"Significance of oxidative stress in human reproduction","volume":"5","author":"Chandra","year":"2009","journal-title":"Arch Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib0995","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1477-7827-3-43","article-title":"Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system","volume":"3","author":"Fujii","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1000","first-page":"111","article-title":"Nitric oxide-induced polycystic ovaries in the wistar rat","volume":"6","author":"Hassani","year":"2012","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/09513590.2011.569607","article-title":"Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase-1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction","volume":"28","author":"Bayram","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3906\/sag-1401-4","article-title":"Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome","volume":"44","author":"Taslipinar","year":"2014","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejogrb.2006.09.009","article-title":"Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity","volume":"133","author":"N\u00e1cul","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03345614","article-title":"The relationship of the interleukin-6-174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients","volume":"31","author":"Erdogan","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2009.07.016","article-title":"Role of the PRMT\u2013DDAH\u2013ADMA axis in the regulation of endothelial nitric oxide production","volume":"60","author":"Pope","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","article-title":"The DDAH\/ADMA\/NOS pathway","volume":"4","author":"Tran","year":"2003","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1035","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1021\/bi973035t","article-title":"Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation","volume":"37","author":"Denu","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1040","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with PCOS","volume":"90","author":"Kravarti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 6","key":"10.1016\/j.ejogrb.2015.05.005_bib1045","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1113\/jphysiol.2012.246918","article-title":"Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary syndrome but can be improved by exercise training","volume":"591","author":"Sprung","year":"2013","journal-title":"J Physiol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1050","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1055","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1161\/ATVBAHA.114.304136","article-title":"Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study","volume":"34","author":"Calderon-Margalit","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1060","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1065","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"De Fronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1085","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular risk, and androgen excess","volume":"98","author":"Wild","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1095","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0002-9378(11)90605-X","article-title":"Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance","volume":"166","author":"Wild","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0015-0282(00)00695-6","article-title":"Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?","volume":"74","author":"Loucks","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1110","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case\u2013control study","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0889-8529(05)70286-3","article-title":"Polycystic ovary syndrome","volume":"26","author":"Goudas","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1120","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1130","first-page":"1266","article-title":"Does carotid intima-media thickness have relationship with polycystic ovary syndrome?","volume":"4","author":"Allameh","year":"2013","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1135","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4103\/2230-8210.103021","article-title":"Study of early atherosclerotic markers in women with polycystic ovary syndrome","volume":"16","author":"Korili","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1145","first-page":"1","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"0","author":"Meyer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1150","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1155","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1210\/jc.2003-032110","article-title":"The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/cs0980531","article-title":"Endothelial dysfunction as a possible link between c-reactive protein levels and cardiovascular disease","volume":"98","author":"Cleland","year":"2000","journal-title":"Clin Sci"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1165","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis","volume":"103","author":"Zwaka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1170","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1175","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.2337\/diacare.26.9.2622","article-title":"Relationship of plasma interleukin-18 concentrations to hyperhomocysteinaemia and carotid intimal-media wall thickness in patients with type 2 diabetes","volume":"26","author":"Aso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/rheumatology\/kel082","article-title":"Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus","volume":"45","author":"Tso","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1185","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1190","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1385\/ENDO:29:3:419","article-title":"Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome","volume":"29","author":"Zhang","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1195","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"Yarali","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1200","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1205","doi-asserted-by":"crossref","first-page":"E375","DOI":"10.1152\/ajpendo.00491.2012","article-title":"Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome","volume":"304","author":"Gonz\u00e1lez","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1210","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2005-2327","article-title":"Increased activation of nuclear factor kappa B triggers inflammation and insulin resistance in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1215","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","article-title":"Evidence of proatherogenic inflammation in polycystic ovary syndrome","volume":"58","author":"Gonz\u00e1lez","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1220","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1230","first-page":"E375","article-title":"Obesity and hyperandrogenism promote atherogenesis in PCOS","volume":"304","author":"Nainggolan","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1235","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2012.00441","article-title":"Contribution of oxidative stress to endothelial dysfunction in hypertension","volume":"3","author":"Silva","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1155\/2009\/465203","article-title":"Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index","volume":"26","author":"Samy","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1245","first-page":"10374","article-title":"Molecular biology and biochemistry of the endothelin","volume":"10","author":"Yanagisawa","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1250","first-page":"13","article-title":"Endothelin, a potent vasoconstrictor, is a vascular smooth mitogen","volume":"1","author":"Dubin","year":"1989","journal-title":"J Vasc Med Biol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1255","first-page":"829","article-title":"Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo","volume":"80","author":"Ferri","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00403325","article-title":"Elevated plasma endothelin in patients with diabetes mellitus","volume":"33","author":"Takahashi","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1265","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1270","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1275","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1280","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.09.010","article-title":"Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects","volume":"204","author":"Rajendrana","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2009.02.002","article-title":"Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo","volume":"206","author":"Hein","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1290","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1295","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1373\/clinchem.2011.169839","article-title":"Endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction","volume":"57","author":"Devaraj","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1300","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","article-title":"A self-fulfilling prophecy: CRP attenuates nitric oxide production and inhibits angiogenesis","volume":"106","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1305","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","article-title":"Demonstration that CRP decreases eNOS expression and bioactivity in human aortic endothelial cells","volume":"106","author":"Venugopal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1310","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.yjmcc.2007.08.015","article-title":"C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling","volume":"43","author":"Singh","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1315","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Serum inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1320","first-page":"323","article-title":"Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome","volume":"15","author":"Makedos","year":"2011","journal-title":"Hippokratia"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1325","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.05.005_bib1330","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0031-1279740","article-title":"Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress","volume":"119","author":"Macut","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151500158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151500158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:34:19Z","timestamp":1759556059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151500158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":133,"alternative-id":["S030121151500158X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.05.005","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress and cardiovascular complications in polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}